25 results  1 of 2 

1 Effects of rosiglitazone, an antidiabetic drug, on Kv3.1 channels
Hyang Mi Lee, Seong Han Yoon, Min-Gul Kim, Sang June Hahn, Bok Hee Choi
Korean J Physiol Pharmacol.2023;27(1):95-103.   Published online 2023 January 1     DOI: http://dx.doi.org/10.4196/kjpp.2023.27.1.95
      
2 The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open state
Hyang Mi Lee, Sang June Hahn, Bok Hee Choi
Korean J Physiol Pharmacol.2022;26(2):135-144.   Published online 2022 March 1     DOI: http://dx.doi.org/10.4196/kjpp.2022.26.2.135
      
3 Beneficial Effects of Aerobic Exercise Training Combined with Rosiglitazone on Glucose Metabolism in Otsuka Long Evans Tokushima Fatty Rats
Shan-Ji Piao, So Hun Kim, Young Ju Suh, Seong-Bin Hong, Seong Hee Ahn, Da Hae Seo, In-Sun Park, Moonsuk Nam
Diabetes Metab J.2017;41(6):474-485.   Published online 2017 November 15     DOI: http://dx.doi.org/10.4093/dmj.2017.41.6.474
      
4 Serial Micro-CT Assessment of the Therapeutic Effects of Rosiglitazone in a Bleomycin-Induced Lung Fibrosis Mouse Model
Eun Jung Choi, Gong Yong Jin, Se Mi Bok, Young Min Han, Young Sun Lee, Myung Ja Jung, Keun Sang Kwon
Korean J Radiol.2014;15(4):448-455.   Published online 2014 July 9     DOI: http://dx.doi.org/10.3348/kjr.2014.15.4.448
      
5 Cell proliferation and neuroblast differentiation in the dentate gyrus of high-fat diet-fed mice are increased after rosiglitazone treatment
Dae Young Yoo, Woosuk Kim, Dae Won Kim, Sung Min Nam, Hyo Young Jung, Jong Whi Kim, Choong Hyun Lee, Jung Hoon Choi, Moo-Ho Won, Yeo Sung Yoon, In Koo Hwang
J Vet Sci.2014;15(1):27-33.   Published online 2014 March 19     DOI: http://dx.doi.org/10.4142/jvs.2014.15.1.27
      
6 Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia
Hyun Ju Lee, Youn Jin Lee, Chang Won Choi, Jin-A Lee, Ee-Kyung Kim, Han-Suk Kim, Beyong Il Kim, Jung-Hwan Choi
Yonsei Med J.2014;55(1):99-106.   Published online 2013 November 29     DOI: http://dx.doi.org/10.3349/ymj.2014.55.1.99
      
7 Post-marketing Surveillance of the Safety and Effectiveness of Rosiglitazone/Metformin in Korean Patients with Type 2 Diabetes
HanKyu Lee, So-Hyun Park, Shin-Young Oh, Yil-Seob Lee
J Korean Soc Clin Pharmacol Ther.2012;20(2):195-204.   Published online 2012 December 31     DOI: http://dx.doi.org/10.12793/jkscpt.2012.20.2.195
      
8 Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
Kun Ho Yoon, Jeong Ah Shin, Hyuk Sang Kwon, Seung Hwan Lee, Kyung Wan Min, Yu Bae Ahn, Soon Jib Yoo, Kyu Jeung Ahn, Sung Woo Park, Kwan Woo Lee, Yeon Ah Sung, Tae Sun Park, Min Seon Kim, Yong Ki Kim, Moon Suk Nam, Hye Soon Kim, Ie Byung Park, Jong Suk Park, Jeong Taek Woo, Ho Young Son
Diabetes Metab J.2011;35(1):26-33.   Published online 2011 February 28     DOI: http://dx.doi.org/10.4093/dmj.2011.35.1.26
      
9 Effects of Rosiglitazone on Inflammation in Otsuka Long-Evans Tokushima Fatty Rats
Jin Woo Lee, Il Seong Nam-Goong, Jae Geun Kim, Chang Ho Yun, Se Jin Kim, Jung Il Choi, Young IL Kim, Eun Sook Kim
Korean Diabetes J.2010;34(3):191-199.   Published online 2010 June 30     DOI: http://dx.doi.org/10.4093/kdj.2010.34.3.191
      
10 Peroxisome Proliferator-activated Receptor-γ Agonist Inhibits Pro-inflammatory Gene Expressions and Cellular Proliferation of Fibroblast Like Synoviocytes from Patients with Rheumatoid Arthritis by Down-regulation of NF-kappaB
Yong-Jin Kwon, Soo-Jin Chung, Tae-Yeon Kim, Min-Chan Park
J Korean Rheum Assoc.2010;17(2):153-161.   Published online 2010 June 23     DOI: http://dx.doi.org/10.4078/jkra.2010.17.2.153
   
11 HDL Cholesterol Reduction during Rosiglitazone and Fenofibrate Treatment in a Type 2 Diabetes Mellitus Patient with Dyslipidemia
Mijeong Im, Minki Kim, Jin Kyung Lee, Yoon Hwan Chang, Dong Young Lee, Seok-Il Hong, Yun Yong Lee, Young Jun Hong
Korean J Lab Med.2010;30(1):17-19.   Published online 2010 January 14     DOI: http://dx.doi.org/10.3343/kjlm.2010.30.1.17
   
12 The Efficacy of Fixed Dose Rosiglitazone and Metformin Combination Therapy in Poorly Controlled Subjects with Type 2 Diabetes Mellitus
Tae Seo Sohn, Jee in Lee, In Ju Kim, Kyung Wan Min, Hyun Shik Son
Korean Diabetes J.2008;32(6):506-512.   Published online 2008 December 31     DOI: http://dx.doi.org/10.4093/kdj.2008.32.6.506
      
13 The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus
Tae Seo Sohn, Jee In Lee, In Ju Kim, Kyung Wan Min, Hyun Shik Son
Korean Diabetes J.2008;32(5):445-452.   Published online 2008 October 31     DOI: http://dx.doi.org/10.4093/kdj.2008.32.5.445
      
14 The Inhibition of Insulin-stimulated Proliferation of Vascular Smooth Muscle Cells by Rosiglitazone Is Mediated by the Akt-mTOR-P70S6K Pathway
Sungha Park, Soyeon Lim, Woochul Chang, Heesang Song, Sunju Lee, Byeong-Wook Song, Hye-Jung Kim, Min-Ji Cha, Eunju Choi, Yangsoo Jang, Namsik Chung, Seung Yun Cho, Ki-Chul Hwang
Yonsei Med J.2008;49(4):592-600.   Published online 2008 August 30     DOI: http://dx.doi.org/10.3349/ymj.2008.49.4.592
      
15 Effects of Rosiglitazone on Heat Shock Protein and the Endothelin System in Deoxycorticosterone Acetate-Salt Hypertensive Rats
Eun Hui Bae, In Jin Kim, Jeong Woo Park, Seong Kwon Ma, Ki Chul Choi, JongUn Lee, Soo Wan Kim
Electrolyte Blood Press.2008;6(1):1-8.   Published online 2008 June 30     DOI: http://dx.doi.org/10.5049/EBP.2008.6.1.1
      
16 Rosiglitazone Activates AMPK and Improves Non-Alcoholic Fatty Liver Disease in OLETF Rats
Eun-Hee Cho, Ki-Up Lee
Korean Diabetes J.2008;32(2):141-148.   Published online 2008 April 30     DOI: http://dx.doi.org/10.4093/kdj.2008.32.2.141
      
17 DPP-4 Inhibitors and the Relations between Rosiglitazone and the Risk of Myocardial Infarction
Hyoung Woo Lee
J Korean Med Assoc.2008;51(4):371-376.   Published online 2008 April 30     DOI: http://dx.doi.org/10.5124/jkma.2008.51.4.371
      
18 The Effect of Chlamydia pneumoniae on the Expression of Peroxisome Proliferator-Activated Receptor-γ in Vascular Smooth Muscle Cells
Yong-Hwan Kim, Si-Young Choi, Jong-Hui Suh, Tae-Kyun Kim, Ki-Bae Seung, Young-Pil Wang, Kiyuk Chang
Yonsei Med J.2008;49(2):230-236.   Published online 2008 April 20     DOI: http://dx.doi.org/10.3349/ymj.2008.49.2.230
      
19 A Case of Macular Edema after Rosiglitazone Use
Taek Hoon Lee, Sun Young Jin, Moon Jeong Choi, Chul Gu Kim, Jong Woo Kim
J Korean Ophthalmol Soc.2007;48(10):1425-1428.   Published online 2007 October 20     DOI: http://dx.doi.org/10.3341/jkos.2007.48.10.1425
      
20 The Effect of Rosiglitazone on Gluose Metabolism and Insulin Sensitivity in Non Obese Type 2 Diabetic Rat Models
Mi Jin Kim, Eui Jong Chung, Byung Wook Ha, Ji Hoon Kim, Su Min Nam, Mi Young Lee, Jang Hyun Kho, Young Goo Shin, Choon Hee Chung
J Korean Diabetes Assoc.2007;31(4):319-325.   Published online 2007 July 31     DOI: http://dx.doi.org/10.4093/jkda.2007.31.4.319
      

 1 of 2